Skip to main content

Table 3 parameters of metabolism, hemostasis endogenous fibrinolysis and blood rheology

From: Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients

  clinical event without clinical event p-value
n = 88 n = 150  
total cholesterol (mg/dl) 243 ± 49 238 ± 44 n.s.
hdl - cholesterol(mg/dl) 44 ± 11 45 ± 12 n.s.
ldl - cholesterol(mg/dl) 182 ± 49 173 ± 41 n.s.
triglycerides (mg/dl) 209 ± 143 185 ± 113 n.s.
lipoproteine (a) (mg/dl) 32 ± 39 34 ± 41 n.s.
uric acid (mg/dl) 5,8 ± 1,6 6,6 ± 1,7 n.s.
glucose (mg/dl) 108 ± 51 92 ± 35 <0,05
tissue -plasminogenactivator (μg/l) 9,3 ± 3,5 8,2 ± 3,0 <0,05
plasminogenaktivator-inhibitore (U/ml) 4,9 ± 2,5 4,9 ± 3,0 n.s.
fibrinogen (mg/dl) 330 ± 65 319 ± 70 n.s.
plasma viscosity (mPa × s-1) 1,3 ± 0,1 1,3 ± 0,2 n.s.
red blood cell aggregation M (E) 7,7 ± 2,4 7,5 ± 2,3 n.s.
red blood cell aggregation M1 (E) 12,4 ± 2,9 12,3 ± 3,0 n.s.
hematocrit (%) 43,6 ± 3,2 43,1 ± 3,1 n.s.